Boehringer Ingelheim GmbH is a pharmaceutical company which concentrates on the development of human pharmaceuticals, biopharmaceuticals, chemicals, and animal health products. The Human Pharmaceuticals sector is the company's largest division, accounting for around 96% of sales. This includes prescription medicines and consumer healthcare products. Boehringer Ingelheim is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA). (via Wikipedia)
Operating Income:
€1.980 billion EUR (2008)
Net Income:
€1.424 billion EUR (2008)
Name:
Boehringer Ingelheim GmbH
Motto:
Value through Innovation
Founded:
Germany (1885)
Products:
Medicines, ie. Aggrenox, Flomax, Micardis, Zantac
No. of Employees:
41,300 (2008)
Type:
Pharmaceuticals/Private
Key People:
Engelbert Tjeenk Willink, Member of the BMD
Dr Andreas Barner, Chairman of the Board of Managing Directors
(BMD)
Hubertus von Baumbach, Member of the Board of Managing Directors
(BMD)
Professor Dr Wolfram Carius, Member of the BMD
Revenue:
€11.595 billion EUR (2008)
Industry:
Pharmaceuticals
Location:
Binger Str. 173
55216 Ingelheim
Germany
Powered by DevHub. Enhanced by Evri
Site Map | Privacy Policy | Directory | Contact | Advertise
This site is not affiliated with Boehringer Ingelheim. It is a fan site and part of the Epik.com direct navigation network. To contribute content to this site, please contact us
